文献速递关节外科

GENESIS II全膝关节置换术至少15年临床结果与生存率

Clinical Results and Survivorship of the GENESIS II Total Knee Arthroplasty at a Minimum of 15 Years.
PubMed 文献 · J Arthroplasty · 2017-02-16

研究回顾1995至1999年接受GENESIS II全膝关节置换术的469例患者,平均随访16年,15年以任何原因翻修为终点的Kaplan-Meier生存率为96.4%(95%CI 95.5%-97.3%),WOMAC与膝关节协会评分较术前显著改善(P<.001),SF-12躯体健康总分显著改善而心理健康总分无变化。

要点

  • 15年以任何原因翻修为终点的生存率为96.4%(95%CI 95.5%-97.3%)。
  • WOMAC与膝关节协会评分从术前至末次随访显著改善(P<.001)。
  • SF-12躯体健康总分显著改善(P<.001),心理健康总分无变化。

核心结论

  • GENESIS II假体设计特征在其临床使用期间保持恒定,在当代全膝关节置换系统中较为罕见,该系统在平均15年时持续表现出优异的长期生存率和健康相关结局改善,代表本机构全膝关节置换系统的标准。

研究设计与样本

  • 从本机构数据库检索1995年至1999年间使用GENESIS II系统行全膝关节置换术的患者,报告Kaplan-Meier生存分析及平均16年时的WOMAC、SF-12和膝关节协会评分。

主要发现

  • 共完成469例全膝关节置换术,患者平均年龄68岁,前瞻性随访平均16年(范围14.8-19.5年)。
  • 15年以任何原因翻修为终点的Kaplan-Meier生存率为96.4%(95%CI 95.5%-97.3%)。
  • WOMAC和膝关节协会评分从术前至末次随访显著改善(P<.001)。
  • SF-12躯体健康总分从术前至末次随访显著改善(P<.001),心理健康总分无变化。

临床怎么用

  • 原文结论指出GENESIS II在平均15年时持续表现出优异的长期生存率和健康相关结局改善,代表本机构全膝关节置换系统的标准。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to examine the 15-year survivorship and long-term clinical outcomes of the GENESIS II total knee arthroplasty (TKA). METHODS: Patients who underwent TKA with the GENESIS II system between 1995 and 1999 were retrieved from our institutional database. We report a Kaplan-Meier survival analysis as well as Western Ontario and McMaster Universities Arthritis Index, the Short Form Health Survey-12 (SF-12), and the Knee Society Scores at a mean of 16 years. RESULTS: Four-hundred sixty-nine TKAs were performed with a mean patient age of 68 years. Patients were followed up prospectively for a mean of 16 years (range, 14.8-19.5 years). The Kaplan-Meier survival analysis at 15 years, with revision for any reason as the end point, was 96.4% (95.5%-97.3%). The Western Ontario and McMaster Universities Arthritis Index and the Knee Society Scores were significantly improved (P < .001) from the preoperative period to the latest follow-up. Patients had a significant improvement (P < .001) from the preoperative to the latest follow-up on the Physical Health Composite Score of the SF-12, but no change was noted on the Mental Health Composite Score of the SF-12. CONCLUSION: The unique design features of the GENESIS II TKA system have remained a constant over the duration of its clinical use, a rarity for contemporary TKA systems which are often altered before the publication of long-term results. The GENESIS II continues to demonstrate excellent long-term survivorship and improvements in health-related outcomes at a mean of 15 years, representing the standard for TKA systems at our institution.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. McCalden RW, Hart GP, MacDonald SJ, et al. Clinical Results and Survivorship of the GENESIS II Total Knee Arthroplasty at a Minimum of 15 Years. J Arthroplasty. 2017. PMID: 28285899. doi:10.1016/j.arth.2017.02.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。